Insight Molecular Diagnostics, Inc. (IMDX)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Insight Molecular Diagnostics EPS Diluted (Quarterly) : -0.3064 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3064 |
| March 31, 2026 | -0.1243 |
| December 31, 2025 | -0.7159 |
| September 30, 2025 | -0.3388 |
| June 30, 2025 | -0.3042 |
| March 31, 2025 | -0.2596 |
| December 31, 2024 | -1.928 |
| September 30, 2024 | -0.9839 |
| June 30, 2024 | -0.3564 |
| March 31, 2024 | -1.130 |
| December 31, 2023 | -1.936 |
| September 30, 2023 | -0.81 |
| June 30, 2023 | -21.37 |
| March 31, 2023 | 0.4022 |
| September 30, 2022 | -1.623 |
| June 30, 2022 | -1.481 |
| March 31, 2022 | -2.231 |
| December 31, 2021 | -7.783 |
| September 30, 2021 | -3.018 |
| June 30, 2021 | -2.338 |
| March 31, 2021 | -0.9544 |
| Date | Value |
|---|---|
| December 31, 2020 | -1.873 |
| September 30, 2020 | -2.017 |
| June 30, 2020 | -2.767 |
| March 31, 2020 | -2.516 |
| December 31, 2019 | -2.919 |
| September 30, 2019 | -2.011 |
| June 30, 2019 | -2.071 |
| March 31, 2019 | -1.657 |
| December 31, 2018 | -2.213 |
| September 30, 2018 | -1.477 |
| June 30, 2018 | -2.328 |
| March 31, 2018 | -2.385 |
| December 31, 2017 | -2.60 |
| September 30, 2017 | -4.40 |
| June 30, 2017 | -2.60 |
| March 31, 2017 | -3.20 |
| December 31, 2016 | -2.20 |
| September 30, 2016 | -2.00 |
| June 30, 2016 | -2.00 |
| March 31, 2016 | -2.40 |
| December 31, 2015 | -2.80 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.222 |
| Agenus, Inc. | 0.0183 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | -0.0232 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.26M |
| Revenue (Quarterly) | 0.239M |
| Total Expenses (Quarterly) | 11.50M |
| Enterprise Value | 65.37M |
| Gross Profit Margin (Quarterly) | -202.5% |
| Profit Margin (Quarterly) | -4.71K% |
| Earnings Yield | -59.65% |
| Normalized Earnings Yield | -47.92 |